HomePURE • OTCMKTS
add
Pure Bioscience, Inc. Common Stock
Previous close
$0.065
Year range
$0.045 - $0.16
Market cap
7.30M USD
Avg Volume
56.45K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | 391.00K | 19.94% |
Operating expense | 952.00K | -16.56% |
Net income | -798.00K | 20.36% |
Net profit margin | -204.09 | 33.60% |
Earnings per share | — | — |
EBITDA | -724.50K | 21.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 202.00K | -63.73% |
Total assets | 574.00K | -47.15% |
Total liabilities | 4.84M | 101.12% |
Total equity | -4.27M | — |
Shares outstanding | 111.86M | — |
Price to book | -1.63 | — |
Return on assets | -241.99% | — |
Return on capital | 1,299.28% | — |
Cash Flow
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -798.00K | 20.36% |
Cash from operations | -544.00K | 38.39% |
Cash from investing | — | — |
Cash from financing | 400.00K | — |
Net change in cash | -144.00K | 83.69% |
Free cash flow | -308.88K | 43.04% |
About
Founded
Aug 24, 1992
Headquarters
Website
Employees
11
